BioHealth News Archive

Maryland should embrace its expertise in building science and tech facilities – Baltimore Business Journal

Maryland should embrace its expertise in building science and tech facilities – Baltimore Business Journal

With its world-class institutions, talent and collaboration, now is the time for Maryland to take the next steps in becoming the nation’s premier science…

Read More
12 Innovations That Will Change Health Care in the 2020s | Time

12 Innovations That Will Change Health Care in the 2020s | Time

Pocket-size ultrasound devices that cost 50 times less than the machines in hospitals (and connect to your phone). Virtual reality that speeds healing in…

Read More

Alexandria Real Estate Equities Pushes Further into the Seattle Biopharma Market | BioSpace

In March 2019, BioSpace wrote about how the BioForest Hotbed area was the fastest-growing life sciences market in the top 10 from 2014 to…

Read More
NIH, Gates Foundation invest $200M to develop gene therapies for developing countries – MedCity News

NIH, Gates Foundation invest $200M to develop gene therapies for developing countries – MedCity News

Although touted as having potential to cure some of the most intractable of human illnesses, gene therapies also carry some eye-popping price tags that…

Read More
The Galien Foundation Honors 2019 Prix Galien Award Recipients

The Galien Foundation Honors 2019 Prix Galien Award Recipients

NEW YORK, Oct. 25, 2019 /PRNewswire/ -- The Prix Galien USA Committee last night honored excellence in the biopharmaceutical and medical industry for research,…

Read More
CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device

CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device

BALTIMORE, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) -- CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)…

Read More
IND Application Submission To FDA For Phase 1 Trial Of Genetically Modified Autologous Cell Therapy For HIV Announced by American Gene Technologies

IND Application Submission To FDA For Phase 1 Trial Of Genetically Modified Autologous Cell Therapy For HIV Announced by American Gene Technologies

ROCKVILLE, Md., Oct. 18, 2019 /PRNewswire/ -- American Gene Technologies (AGT) announced today the submission of an Investigational New Drug (IND) application to the U.S. Food…

Read More
Maryland Legislature Approves Changes to Maryland General Corporation Law and Maryland REIT Law – Lexology

Maryland Legislature Approves Changes to Maryland General Corporation Law and Maryland REIT Law – Lexology

The General Assembly of Maryland has enacted Senate Bill 137 (the "General Corporate Legislation"), which makes several changes to the Maryland General Corporation Law…

Read More
Why do startups fail?

Why do startups fail?

Why do startups fail? Image: https://www.linkedin.com {iframe}https://www.linkedin.com/posts/mikethomasceo_why-do-startups-fail-activity-6591792572488830976-VbLf/{/iframe}

Read More
United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study

United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and…

Read More
GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments – Reuters

GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments – Reuters

(Reuters) - GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said on…

Read More
Emergent BioSolutions to Host 2019 Analyst & Investor Day NYSE:EBS

Emergent BioSolutions to Host 2019 Analyst & Investor Day NYSE:EBS

GAITHERSBURG, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the company will host an analyst and investor…

Read More
MockV Solutions Announces Collaboration Focused on Predicting Viral Clearance During AAV Bioprocess Development – MockV Solutions

MockV Solutions Announces Collaboration Focused on Predicting Viral Clearance During AAV Bioprocess Development – MockV Solutions

Rockville, MD – October 16, 2019 – MockV Solutions, Inc. (MockV or the Company), a company developing innovative products to analyze viral clearance during process…

Read More
BioTalk from the BioHealth Capital Region Investor Forum – Gentian’s CEO Dr. Hilja Ibert, Ph.D.

BioTalk from the BioHealth Capital Region Investor Forum – Gentian’s CEO Dr. Hilja Ibert, Ph.D.

Gentian’s CEO Dr. Hilja Ibert, Ph.D., guests on BioTalk from the BioHealth Capital Region Investor Conference to talk about their presence in the US…

Read More
CareFirst BCBS partners with D.C. incubator to support health startups

CareFirst BCBS partners with D.C. incubator to support health startups

CareFirst BlueCross BlueShield's corporate investment and innovation organization, Healthworx, has partnered with the Washington, D.C.-based Halcyon incubator program to provide funding and support for…

Read More